The Rare Anemia and Iron Disorder Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center provides comprehensive medical evaluation and treatment for children with all types of rare anemias and iron disorders, including:
We also provide ongoing medical management, counseling and support, and access to new treatment approaches through clinical research.
Rare anemias are diagnosed through careful review of blood and urine tests. These tests may involve a microscopic review of the peripheral blood and a marrow exam. Iron disorders are diagnosed through laboratory testing, iron challenge, and MRI or iron burden assessment. In some cases, a patient may have no known diagnosis, yet the symptoms are present in multiple family members. These families are often invited to participate in research studies aimed at establishing the diagnosis though genetic discovery. Findings that come out of this research can then be translated into innovative new therapies.
The strength of our expertise and facilities enables us to prescribe the most appropriate treatment for each and every diagnosis. A treatment plan may include red blood cell transfusions, intravenous immune globulin to strengthen the immune system, an iron-rich diet or iron supplements, exchange transfusions to replace damaged blood with fresh blood, surgery, immunosuppressive therapy, or partial exchange transfusions to slowly remove and replace a large portion of a patients blood volume.
Dana-Farber/Boston Children's patients have access to the broadest set of blood disorder expertise and pediatric subspecialties available. The breadth of our expertise allows us to assemble a team of specialists to meet the specific needs of the patient.
Our treatment teams are led by a pediatric hematologist who specializes in inherited iron deficiency disorders, sideroblastic anemia, and iron overload. We also have nurse practitioners and physician assistants who specialize in treating anemias, hemoglobinopathies, and red blood cell disorders and a designated hematology patient coordinator. When necessary, we can augment our team with pediatric hematologist/oncologists and pediatric hematopathologists.
Physicians and scientists in our program conduct clinical and laboratory research to increase knowledge of anemia and red blood cell disorders and their treatment. Our clinical research program offers unique access to clinical trials in which children can receive the latest treatments. A major focus of our research program is the rapid translation of scientific discoveries to the bedside to benefit patients.
Our physician/scientists discovered a gene for a rare form of inherited iron deficiency that may provide clues to iron deficiency in the general population, particularly iron deficiency that doesn’t respond to iron supplements. Through this and other research, our physicians work to improve therapeutic approaches and outcomes for all forms of clotting disorders.
U.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.